Clinical Trial Update: HCW9218 for Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1/Phase 2 study of HCW9218 in advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• HCW9218

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Advanced Pancreatic Carcinoma | Phase 1, Phase 2 | Status: COMPLETED